Skip to content

Clinical trials

Phase 2 Carcinoma, Non-Small-Cell Lung trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Country / region: South Korea Clear all

191 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20042
20052
20067
20075
20089
200910
20106
201112
201210
20139
20147
201512
20163
20179
20188
201912
202010
202115
202215
202311
20246
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed93
Unknown status37
Active, not recruiting24
Terminated21
Recruiting13
Not yet recruiting1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yonsei University17
AstraZeneca13
Samsung Medical Center12
National Cancer Center, Korea11
Eli Lilly and Company10
Novartis Pharmaceuticals10
Pfizer9
Hoffmann-La Roche8
GlaxoSmithKline5
Janssen Research & Development, LLC5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung191
Lung Neoplasms36
Neoplasms13
Neoplasm Metastasis9
Adenocarcinoma of Lung8
Melanoma7
Pancreatic Neoplasms6
Brain Neoplasms5
Breast Neoplasms5
Colorectal Neoplasms5

Trials

Showing 1 to 25 of 191. Each trial links to its page on Pharma Observatory.

91 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.